Science Explorer Back to mapMap
Discussion
Researcher · Theageneio General Hospital · Greece

Konstantinos Zervas

Konstantinos Zervas publishes mostly in Hematology, Oncology and Genetics, on topics such as Multiple Myeloma Research and Treatments, Cancer Treatment and Pharmacology and Chronic Lymphocytic Leukemia Research.

ORCID 0000-0003-3670-7908 OpenAlex
World rank
#1,910,554
of 7,710,434 ranked researchers
Rank in Greece
#7,989
of 33,280
Works
104
Citations
4.1k
Citations per work
39.4
h-index
31
i10-index 51Top 11% in Hematology
Konstantinos Zervas

What does Konstantinos Zervas research?

Konstantinos Zervas's work is mostly in Medicine (67%), Biochemistry, Genetics and Molecular Biology (10%).

Health Sciences: 69 works · 66.7% of their workMedicine: 69 works · 66.7% of their workHematology: 29 works · 27.5% of their workOncology: 17 works · 16.8% of their workGenetics: 13 works · 12.4% of their workPathology and Forensic Medicine: 6 works · 6.2% of their workPublic Health, Environmental and Occupational Health: 4 works · 3.8% of their workEverything else: 24 works · 23.0% of their workLife Sciences: 11 works · 10.3% of their workBiochemistry, Genetics and Molecular Biology: 11 works · 10.3% of their workMolecular Biology: 11 works · 10.3% of their workTHEIR WORKKonstantinosZervas104works
Life Sciences10%Health Sciences67%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine6966.7%
  2. Everything else2423.0%
    1. Biochemistry, Genetics and Molecular Biology1110.3%
  1. 1Hematology28% of their works
  2. 2Oncology17% of their works
  3. 3Genetics12% of their works
  4. 4Molecular Biology10% of their works
  5. 5Pathology and Forensic Medicine6% of their works
  6. 6Public Health, Environmental and Occupational Health4% of their works

Research topics

Which keywords describe Konstantinos Zervas's research?

The keywords of their largest research topics: Diagnosis Criteria, International Myeloma Working Group, Rituximab, PET Imaging, Chemotherapy-Induced Peripheral Neuropathy, Taxanes, Chronic Lymphocytic Leukemia and Genomic Aberrations.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Diagnosis Criteria561 topic
  2. International Myeloma Working Group561 topic
  3. Rituximab382 topics
  4. PET Imaging242 topics
  5. Chemotherapy-Induced Peripheral Neuropathy231 topic
  6. Taxanes231 topic
  7. Chronic Lymphocytic Leukemia221 topic
  8. Genomic Aberrations221 topic
  9. Classification161 topic
  10. Lymphoma161 topic
  11. BET Bromodomains91 topic
  12. Cardiac Amyloidosis91 topic
  13. PROTACs91 topic
  14. Transthyretin91 topic
  15. Bisphosphonates81 topic
  16. Fibroblast Activation Protein81 topic
  17. Osteonecrosis of the Jaw81 topic
  18. Tumor Microenvironment81 topic

Where does Konstantinos Zervas work?

Konstantinos Zervas's main affiliation in the publication record is Theageneio General Hospital, Greece.

How many publications and citations does Konstantinos Zervas have?

OpenAlex counts 104 works and 4,098 citations for Konstantinos Zervas, an h-index of 31, ranking #1,910,554 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Konstantinos Zervas. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.